Literature DB >> 18316671

Clinical trials in bipolar mania: implications in study design and drug development.

Mauricio Tohen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18316671     DOI： 10.1001/archgenpsychiatry.2007.44

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  4 in total

Review 1.  A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder.

Authors:  Nancy DiazGranados; Carlos A Zarate
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

Review 2.  Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder.

Authors:  Carlos A Zarate; Husseini K Manji
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

3.  Treatment Guidelines in Bipolar Disorders and the Importance of Proper Clinical Trial Design.

Authors:  Mauricio Tohen
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

4.  Suicidality and Illness Course Worsening in a Male Patient with Bipolar Disorder during Tamoxifen Treatment for ER+/HER2+ Breast Cancer.

Authors:  Claudia Carmassi; Francesco Pardini; Valerio Dell'Oste; Annalisa Cordone; Virginia Pedrinelli; Marly Simoncini; Liliana Dell'Osso
Journal:  Case Rep Psychiatry       Date:  2021-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.